Quotes

Back To Menu

Nippon India Pharma Fund (IDCW) Equity - Pharma
INVEST

Plan: OPEN | Option: Dividend | Sailesh Raj Bhan

25 Jul 24 | 12:00 AM

120.61 0.63 (0.53%)

  • Underperforms

    42.10%

    Return (1Y)

    underperformed BSE Healthcare TRI by -6.22%

  • Less Volatile

    0.74%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.18%

  • Inconsistent

    3/8

    Months

    Has underperformed Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Nippon India Pharma Fund (IDCW), has underperformed by -6.22% (CAGR difference)

42.10%

Underperforms

This is Alpha

Performance Chart for Rs

Invested in

01 Sep 2023

Risk

In last 1 year , the volatility of Nippon India Pharma Fund (IDCW) is Lower than by -0.18%

0.74%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 3 out of Last 8 Months, i.e 37.5% of the times It underperformed its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition